hiPSC-RPE 3 (AMD 3) NAM
Homo sapiens
source_name
hiPSC-RPE 3 treated with Nicotinamide for 3 weeks
gender
male
age
89
disease status
Age related Macular degeneration (AMD)
treatment
Nicotinamide
tissue of origin
RPE